Frankly, JEPI Been 2026: Is It Time to Move on Now?
JEPI has struggled to keep up with a rallying market in 2026, fueling debate over whether its income strategy still f...
Stay within budget with practical, repeatable habits that reinforce good spending choices and support your financial goals.
22,060 articlesJEPI has struggled to keep up with a rallying market in 2026, fueling debate over whether its income strategy still f...
Defensive plays gain traction as markets cool. Here are three consumer staples stocks before the end of June that com...
Moderna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
CME Group announced it will file a lawsuit against the CFTC after the regulator approved Bitcoin perpetual futures in...
Cardano faces a pivotal test as founder Charles Hoskinson lays out a four-layer rescue plan blending governance refor...
Two chipmakers with different playbooks face the 2026 market. This guide breaks down Marvell Technology and Semtech, ...
When the AI rally paused, investors turned to dependable dividend names. Johnson Johnson, Altria, and Verizon led gai...
Investors are eyeing a potential rebound for Figma as enterprise adoption grows and AI-driven updates sharpen the pla...
As MiCA tightens EU crypto rules, licensed platforms race to absorb deposits from non-compliant venues. european cryp...
New analysis challenges the panic around RMDs for average savers. For a 62-year-old with a typical IRA balance, the f...
A recent sale of 25,000 ALHC shares by Alignment Healthcare’s vice chairman has investors wondering about the stock’s...
Pfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...